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Abstract
 
During B lymphoid ontogeny, assembly of the pre–B cell receptor (BCR) is a principal develop-
mental checkpoint at which several Src-related kinases may play redundant roles. Here the Src-
related kinase Blk is shown to effect functions associated with the pre-BCR. B lymphoid expression
of an active Blk mutant caused proliferation of B progenitor cells and enhanced responsiveness
of these cells to interleukin 7. In mice lacking a functional pre-BCR, active Blk supported
maturation beyond the pro–B cell stage, suppressed V
 
H 
 
to DJ
 
H 
 
rearrangement, relieved selection
for productive heavy chain rearrangement, and stimulated 
 
  
 
rearrangement. These alterations
were accompanied by tyrosine phosphorylation of immunoglobulin 
 
  
 
and Syk, as well as
changes in gene expression consistent with developmental maturation. Thus, sustained activation
of Blk induces responses normally associated with the pre-BCR.
Key words: B cell development • signal transduction • allelic exclusion • V(D)J recombination • 
Src kinases
 
Introduction
 
Ig
 
  
 
heavy chain genes are assembled from discrete segments
by V(D)J recombination, a process initiated by RAG-1 and
RAG-2 (1). The joining of coding segments is random
with respect to reading frame, and most primary products
of V(D)J recombination are nonproductive. Heavy chain
gene assembly begins in pro–B cells with the formation of
DJ
 
H 
 
joints on both alleles. V
 
H 
 
to DJ
 
H 
 
joining is then acti-
vated sequentially at the two alleles. Productive assembly of
a heavy chain gene and expression of an intact 
 
  
 
chain
marks the transition from the pro–B to the pre–B cell stage
of development (2).
At this developmental checkpoint, the 
 
  
 
chain associates
with the chaperones VpreB and 
 
 
 
5 and is incorporated,
with the accessory chains Ig
 
  
 
and Ig
 
 
 
, into the pre–B cell
receptor (BCR). The pre-BCR signals several cellular re-
sponses, including: (a) cessation of further V
 
H 
 
to DJ
 
H 
 
joining,
(b) increased sensitivity to IL-7, (c) cell proliferation, (d)
suppression of apoptosis, (e) developmental progression,
and (f) activation of rearrangement at the Ig
 
  
 
locus (for review
see references 3 and 4). The combined proliferative and
antiapoptotic pre-BCR signals contribute to the expansion
of Ig
 
 
 
-expressing clones. Increased responsiveness to IL-7,
by allowing proliferation and survival at diminished cytokine
concentrations, may function in the positive selection of
cells that have undergone productive heavy chain rear-
rangement and developmental progression to light chain
rearrangement (4, 5).
Although the molecular details of signaling through the
pre-BCR are poorly understood, genetic approaches have
identified several critical components of the signaling machin-
ery. In mice lacking Ig
 
 
 
, Ig
 
 
 
, 
 
 
 
5, the tyrosine kinase Syk,
or the docking protein BLNK, B cell development beyond
the pre–B cell stage is impaired, as evidenced by a marked
reduction in the number of peripheral B cells and an increase
in the proportion of B220
 
  
 
CD43
 
  
 
progenitor B cells in
the bone marrow relative to the more mature B220
 
 
 
CD43
 
  
 
cells (6–10).
The intracellular signaling events after appearance of the
pre-BCR are not clearly defined, but several lines of evidence
indicate a role for phosphorylation of Ig
 
  
 
and Ig
 
 
 
. First, in
RAG-deficient mice, cross-linking of Ig
 
  
 
induces tyrosine
phosphorylation of Ig
 
  
 
and Syk, as well as differentiation of
pro–B cells to small pre–B cells (11). Second, in mice lacking
the membrane-bound form of Ig
 
 
 
, Ig
 
  
 
cross-linking sup-
presses heavy chain rearrangement and activates light chain
rearrangement (12). Third, in mice lacking the cytoplasmic
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domain of Ig
 
 
 
, development beyond the pro–B cell stage is
dependent on the Ig
 
  
 
ITAM motifs (13). Fourth, pre-
BCR cross-linking is associated with an increase in the
amount of tyrosine-phosphorylated Ig
 
  
 
that is associated
with the pre-BCR in lipid rafts (14).
The Src-related tyrosine kinases Blk, Lyn, and Fyn asso-
ciate with the BCR, and current models of BCR or pre-
BCR signaling propose that one or more of these Src fam-
ily kinases, possibly in combination with Syk, participate in
phosphorylation of the Ig
 
  
 
and Ig
 
  
 
ITAM motifs (for re-
view see reference 15). Blk and Lyn prefer similar consen-
sus substrate sequences, distinct from that of Src and resem-
bling sites in the Ig
 
  
 
and Ig
 
  
 
ITAM motifs (16). Blk, Lyn,
and Fyn play functionally redundant roles in supporting the
pro–B to pre–B cell transition. Single or pairwise deficien-
cies of these or other Src-like kinases have little or no effect
on early B cell development (17–24). In contrast, the pro–B
to pre–B cell transition is attenuated in triply mutant Blk
 
 
 
/
 
 
 
Lyn
 
 
 
/
 
  
 
Fyn
 
 
 
/
 
  
 
mice (25). Thus, any one of these three ki-
nases is essential for effective pre-BCR signaling.
Although loss of function mutations have revealed a re-
dundant requirement for Blk, Lyn, or Fyn in B cell devel-
opment, gain of function mutations, by revealing the conse-
quences of kinase activation, would be expected to provide
additional mechanistic insight. To this end we asked
whether a constitutively active form of Blk, the only mem-
ber of the group expressed preferentially in B cells, could
provide some or all of the functions associated with the pre-
BCR. Our results indicate that in B cell progenitors, active
Blk mimics several consequences of pre-BCR signaling.
 
Materials and Methods
 
Mice.
 
The transgenic line Blk(Y495F)-15 (B6 
 
  
 
SJL), bear-
ing a cDNA encoding Blk(Y495F) under control of the H-2
 
k
 
promoter and the Ig
 
  
 
intronic enhancer, has been described (26).
 
 
 
MT mice (C57BL/6 background; reference 27) were obtained
from The Jackson Laboratory. RAG-2–deficient mice (129S6
background; reference 28) were obtained from Taconic Labora-
tories. Blk(Y495F) transgenic mice deficient in membrane-bound
Ig
 
  
 
or in RAG-2 were generated by interbreeding Blk(Y495F)
transgenic and 
 
 
 
MT or RAG2-deficient mice, respectively.
 
Cell Culture.
 
Cells were maintained in RPMI 1640 supple-
mented with 10% FCS, 50 u/ml penicillin/streptomycin, 1 mM so-
dium pyruvate (Sigma-Aldrich), 2 mM 
 
l
 
-glutamine (GIBCO BRL),
50 
 
 
 
M 
 
 
 
-mercaptoethanol, 10 mM Hepes, and 0.7 
 
  
 
MEM nones-
sential amino acids (GIBCO BRL) at 37
 
 
 
C in 5% CO
 
2
 
.
For thymidine uptake assays, bone marrow cell suspensions
from 3–4-wk-old mice were cultured with 10 ng/ml rIL-7 for
5 d, by which time the nonadherent cell population contained
 
 
 
95% B220
 
  
 
cells, 
 
 
 
80% of which were also CD43
 
 
 
. Triplicate
samples of B220
 
  
 
CD43
 
  
 
cells were separated from dead cells by
ficoll centrifugation, washed three times with PBS, and incubated
with rIL-7 or media alone in 96-well plates at 10
 
5 
 
cells per well.
Thymidine incorporation was assayed after 3 d of culture after the
addition of [
 
3
 
H]thymidine (1 
 
 
 
Ci/well) 16 h before assay.
For isolation of RNA or protein, B220
 
  
 
CD43
 
  
 
cells were
cultured as described above, but for 10 d in the presence of 10
ng/ml IL-7 added every 3 d of culture. Cell concentration was
maintained below 10
 
6
 
/ml.
 
Flow Cytometric Analysis.
 
Bone marrow cells or splenocytes
from 3–5-wk-old mice were analyzed on a FACScan™ instru-
ment (Becton Dickinson). The following mAbs were obtained
from BD Biosciences: FITC-conjugated anti-CD43 (S7 clone),
anti–c-kit (CD117), anti-CD24 (HSA), anti–BP-1, anti-CD22,
and anti-CD2; PE-conjugated anti-CD43, anti–BP-1, anti-
CD22, anti-CD25, and anti-B220; and Cy3-conjugated anti-
B220. FITC-conjugated anti-IgM and PE-conjugated anti-IgD
were obtained from Southern Biotechnology Associates, Inc.
Cells stained with PKH26 (Sigma-Aldrich) or annexin V (BD
Biosciences) were counterstained with anti–B220-Cy3 and anti–
CD43 (S7 clone)-FITC or anti–BP-1 (BD Biosciences).
 
V(D)J Recombination Assays.
 
DNA from B220
 
  
 
CD43
 
  
 
or
unsorted bone marrow cells was assayed for rearrangement by
PCR as previously described, using primers specific for the V
 
H
 
VJ558 family, for the DFL16 and DSP2 families, for V
 
  
 
segments,
for the J
 
H
 
3 region, and for the J
 
 
 
2 region (29). Products were de-
tected by hybridization to 
 
32
 
P-labeled probes (30). The ligation-
mediated PCR assay for signal end breaks was performed using
the linker-specific primer BW-1 and one of the locus-specific
primers 
 
 
 
02, 
 
 
 
03, or DFL16.1B (31). Products were detected by
hybridization to 
 
32
 
P-labeled probes specific for the germline
C
 
 
 
0-JH3 region, the region 5
 
  
 
of DFL16.1, or the germline
C
 
 
 
0-C
 
 
 
2 region.
 
Analysis of Protein Tyrosine Phosphorylation.
 
Cells were lysed in
a buffer containing 50 mM TrisCl, pH 8.0, 150 mM NaCl, 1%
NP-40, 1% deoxycholic acid, 0.1% SDS, 1 mM NaVO
 
3
 
, 1 mM
PMSF, and 10 
 
 
 
g each leupeptin, aprotinin, and pepstatin. Anti-
bodies against Syk (Santa Cruz Biotechnology, Inc.) or CD79b
(Southern Biotechnology Associates, Inc.) were affixed to protein
A/G agarose. 10 
 
 
 
g antibody was incubated overnight with cell ly-
sate (5 
 
  
 
10
 
7 
 
cell equivalents) at 4
 
 
 
C. Beads were collected by cen-
trifugation and washed in lysis buffer. Immunoprecipitates were
fractionated by SDS-PAGE and phosphotyrosine was detected by
immunoblotting with antibody 4G10 (Upstate Biotechnology).
 
RNA Isolation and Analysis.
 
Total RNA was extracted from
cell suspensions using the TRIzol reagent (Invitrogen). 1 
 
 
 
g total
polyadenylated mRNA, isolated by adsorption to oligo-dT–
coated beads (Oligotex; QIAGEN), was used as a template for
synthesis of double stranded cDNA using reverse transcriptase (Su-
perscript II; Invitrogen) and a T7-(dT)
 
24 
 
primer. Biotin-labeled
cRNA probes for array hybridization were transcribed from
cDNA templates using T7 RNA polymerase (Enzo Biochem).
For RT-PCR, 1 
 
 
 
g total RNA was synthesized using reverse
transcriptase (Superscript II; Invitrogen) and random hexameric
primers. Reverse transcripts were amplified by PCR. Sequences
of oligonucleotide primers are provided in Table S4, available at
http://www.jem.org/cgi/content/full/jem.20030729/DC1.
 
Oligonucleotide Array Hybridization and Data Analysis.
 
Biotin-
labeled cRNA probes were hybridized to oligonucleotide mi-
croarrays (mouse U74Av2; Affymetrix, Inc.) containing 12,488
probe sets. Transcripts that were scored by Affymetrix Microarray
Suite as present on at least one array were analyzed using Gene-
Spring 4.0 (Silicon Genetics). The signal intensity of each probe
set was normalized to the median value of all intensities measured
in the corresponding array, and then further normalized to the
median of all array-normalized intensities determined for that
gene over all hybridizations. Three sets of genes were selected for
further study. A gene was included in the first set if (a) its normal-
ized expression in Blk(Y495F) transgenic samples deviated from
expression in nontransgenic controls by at least twofold and (b) its
expression deviated from that of the control samples with a signif-
icance cutoff of P 
 
  
 
0.01 (Welch’s approximate 
 
t
 
 test). A gene 
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was included in the second set if it was (a) absent from all control
arrays but present in all transgenic arrays or (b) present in all con-
trol arrays but absent from all transgenic arrays. A gene was in-
cluded in the third set if its normalized expression differed by
more than fivefold between transgenic and nontransgenic sam-
ples. Hierarchal clustering was performed using the standard cor-
relation coefficient as a distance metric.
 
Online Supplemental Material.
 
Fig. S1 supplements Fig. 2 and
shows the effect of Blk (Y495F) on expression of the B cell devel-
opmental markers CD24, CD25, CD2, and c-kit in RAG-defi-
cient or 
 
 
 
Mt/
 
 
 
MT mice, as assessed by fluorescence cytometry.
Table S1 shows the distribution of B220 CD43
 
 
 
 and B220
CD43
 
 
 
 cells in the bone marrow of RAG-deficient or 
 
 
 
MT/
 
 
 
MT mice expressing the Blk (Y495F) transgene. Table S2
shows the distribution of B220 IgM
 
 
 
 and B20 IgM
 
 
 
 B cells in
the spleens of Blk (Y495F) transgenic mice. Table S3 supple-
ments Fig. 6 C and assigns the differently expressed genes of
known function to functional categories. Table S4 depicts the
primer pairs used for RT-PCR, whose results are shown in
Fig. 6 D. Fig. S1 and Tables S1–S4 are available at http://
www.jem.org/cgi/content/full/jem.20030729/DC1.
 
Results
 
Expansion of B Cell Progenitors in Bone Marrow of
Blk(Y495F) Transgenic Mice.
 
We first considered whether
active Blk might deliver proliferative signals independent of
pre-BCR expression using a line of transgenic mice,
Blk(Y495F)-15, in which a constitutively active Blk mu-
tant is expressed specifically in the B lymphoid lineage (26).
Bone marrow B lymphoid progenitors from 3–5-wk-old
 
Table I.
 
Phenotypic Analysis of B220
 
  
 
Bone Marrow Populations in Nontransgenic and Blk(Y495F) Transgenic Mice
 
Genotype
No.
mice
No. total
BM 
 
  
 
10
 
 
 
6
 
Percent
B220
 
 
 
Percent
B220
 
  
 
CD43
 
 
 
CD22
 
lo/
 
 
Percent
B220  CD43int
CD22int
Percent
B220  CD43  IgM 
CD22lo
Percent
B220  IgM 
CD22hi
Nontransgenic 3 22.4   1.2 37.7   2.9 9.2   0.5  4.5   1.5 12.5   1.7 12.4   0.6
Blk(Y495F) 3 23.4   0.4 45.9   2.6 3.9   0.2 34.1   1.6 4.3   0.3 4.9   0.5
B220  lymphocyte populations were identified by flow cytometry as described in Materials and Methods and Fig. 1 A. Bone marrow samples were
collected from 3–5-wk-old mice in littermate groups. Percentages are defined according to a lymphocyte gate in which 12,000 events were acquired
for each mouse. Total cellularity is derived from the number of gated events. Mean values   SEM are given.
Figure 1. (A) Overrepresentation
of B220  CD43int cells in bone mar-
row of Blk(Y495F) transgenic mice.
Bone marrow cell suspensions from
3–4-wk-old transgenic or nontrans-
genic littermates were stained for
B220 and additional surface markers
as indicated. Plots of BP-1 or CD22
versus CD43 were gated on B220 
cells. Numbers indicate percentages
of cells in the corresponding quad-
rants. (B) Hyperproliferation of
Blk(Y495F) transgenic B cell pro-
genitors. Bone marrow cells from
transgenic or nontransgenic litter-
mates were labeled with PKH26 and
maintained in the presence of 20 ng/
ml IL-7. At 3 d, cells were counter-
stained for B220, CD43, and BP-1.
Top and middle panels show PKH-26
fluorescence gated on nontransgenic
B220  CD43  or B220  CD43  pop-
ulations. Bottom panel shows PKH26
fluorescence gated on the transgenic
B220  CD43int population. (C) Hy-
perresponsiveness of Blk(Y495F)
transgenic B cell progenitors to IL-7.
Proliferation of B cell progenitors
from nontransgenic ( ) or trans-
genic ( ) littermates in response to
IL-7 was assayed by [3H]thymidine
incorporation (mean   SEM of three
independent trials) as described in
Materials and Methods.Pre–BCR Signaling by Active Blk 1866
transgenic mice and nontransgenic littermates were exam-
ined. Blk(Y495F) transgenic and nontransgenic mice
showed similar bone marrow cellularity. Transgenic mice,
however, exhibited a slight increase in the percentage of
B220  bone marrow cells (Table I).
Phenotypic analysis revealed an expanded subset of
B220   bone marrow cells with a CD43-intermediate
(CD43int) phenotype, reminiscent of cells at the pro–B to
pre–B cell transition (Fig. 1 A and Table I). The CD43int
population was homogeneously BP-1high and CD22int and
comprised 74.1   6.2% of the B220  bone marrow com-
partment. In contrast, B220  CD43  and B220  CD43 
cells comprised 24.5   1.7% and 75.5   9.5%, respectively,
of the B220  bone marrow compartment in nontransgenic
mice. The transgenic animals also exhibited decreases in
pro–B cells (B220  CD43  CD22lo/ ) and late pre–B cells
(B220  CD43  CD22lo IgM ; reference 32). In addition,
the B220  IgM  population was relatively diminished in
transgenic mice. With respect to their CD22int phenotype,
these cells resemble a B progenitor population that accumu-
lates in RAG-deficient mice bearing a   heavy chain trans-
gene and is expanded upon coexpression of Bcl-2 (33).
The distribution of DJH rearrangements from bone mar-
row cells was consistent with a polyclonal expansion of B
cell progenitors in Blk(Y495F) transgenic mice (not de-
picted). The polyclonality of the B cell expansion in the
3–5-wk-old transgenic mice stands in contrast to the
clonality of the B220  CD43  tumors that arise in these an-
imals after a protracted latency period of 6–12 mo (26).
Increased IL-7 Responsiveness of B Cell Progenitors from
Blk(Y495F) Transgenic Mice. The accumulation of B220 
CD43int  cells in the bone marrow suggested that
Blk(Y495F) had stimulated cellular proliferation. To exam-
ine this, bone marrow cells were loaded ex vivo with PKH-
26 and cultured with IL-7 at 20 ng/ml in the presence of
autologous stromal cells. After 3 d, the PKH-26 signal re-
mained undiluted in 22 and 69% of the nontransgenic
B220  CD43  and B220  CD43  populations, respectively
(Fig. 1 B). In contrast, only 8% of viable B220  CD43int
cells from Blk(Y495F) mice had not undergone cell division
by 3 d, as evidenced by PKH-26 fluorescence (Fig. 1 B).
Gating of transgenic samples on B220  CD43  and B220 
CD43  populations yielded similar results, as expected be-
cause the majority of B220  cells in transgenic bone marrow
are homogeneously B220  CD43int (unpublished data).
To determine whether the Blk(Y495F) transgene could
confer hypersensitivity to IL-7, we cultured bone marrow
from transgenic or nontransgenic mice for 5 d under con-
ditions that favor outgrowth of B220  CD43  cells. Non-
adherent cells were stimulated with increasing amounts of
IL-7 in the absence of stromal cells. Thymidine incorpora-
tion was measured after 3 d of restimulation (Fig. 1 C). The
maximal proliferative response of cells from Blk(Y495F)
transgenic mice was more than twice that of cells from
nontransgenic animals (17,457   1,501 cpm vs. 8,434  
2,079 cpm) and we observed a shift in IL-7 sensitivity.
Cells from transgenic mice responded to IL-7 at concentra-
tions as low as 20 pg/ml, whereas cells from nontransgenic
animals required a 10-fold higher concentration for a simi-
lar response. In this respect, pro–B cells from Blk(Y495F)
transgenic mice resembled   heavy chain transgenic pro–B
cells, which also exhibit a lower threshold for responsive-
ness to IL-7 (5).
We asked whether differences in the frequency of apop-
tosis might contribute to the outgrowth of B cell progeni-
tors in the transgenic animals. In freshly isolated B lym-
phoid progenitors from bone marrow of Blk(Y495F)
transgenic mice, we observed slight decreases in the apop-
totic fraction, as defined by annexin V staining, relative to
wild-type. This held whether we gated on B220  CD43 
Figure 2. Expression of Blk(Y495F) circumvents devel-
opmental blocks in RAG-deficient or  MT/ MT mice.
(A) Bone marrow cell suspensions were prepared from 3–5-
wk-old RAG-2 /  mice bearing the Blk(Y495F) transgene
(right), or from age-matched, nontransgenic RAG-2 / 
littermates (left). Cells were stained with an anti-B220
antibody and counterstained with antibodies for additional
surface markers as indicated. Numbers indicate percentages
of cells in the corresponding quadrants. (B) Analysis, as in
A, of bone marrow cells from 3–5-wk-old  MT/ MT
mice bearing Blk(Y495F) transgene (right), or from age-
matched, nontransgenic  MT/ MT littermates (left).Tretter et al. 1867
(16.1   1.5 in transgenic vs. 22.8   2.7 in wild-type) or
B220  CD43  (15.8   1.6 in transgenic vs. 18.1   1.4 in
wild-type) cells. These observations suggest that the accu-
mulation of B cell progenitors expressing Blk(Y495F) re-
sults primarily from increased proliferation.
Constitutively Active Blk Overcomes Developmental Blocks in
RAG-2    and  MT/ MT Mice. In mice lacking RAG-2,
B lymphoid development is arrested at the CD43  pro–B
cell stage (Fig. 2 A; reference 28). This block can be over-
come by introduction of a   transgene (34). To test the
ability of the Blk(Y495F) mutant to bypass the requirement
for   heavy chain in signaling the pro–B to pre–B cell tran-
sition, Blk(Y495F) transgenic animals were crossed with
RAG-2–deficient mice. A B220   CD43int  population
emerged in the bone marrow of RAG-2–deficient mice
bearing the Blk(Y495F) transgene, indicating developmen-
tal progression beyond the CD43  pro–B cell stage (Fig. 2
A and Fig. S1 and Table S1, which are available at http://
www.jem.org/cgi/content/full/jem.20030729/DC1). The
appearance of the differentiation markers BP-1 and CD22,
increased expression of CD24 (HSA) and CD2, and de-
creased expression of c-kit were all consistent with this in-
terpretation (Fig. 2 A and Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20030729/DC1).
Therefore, these cells resembled the expanded CD43int
population we observed in Blk(Y495F) RAG-2 /  mice.
We then asked whether Blk(Y495F) could support pro-
gression to light chain gene rearrangement in the absence
of the pre-BCR. To do so, we crossed transgenic animals
with  MT/ MT mice (27), in which the pre-BCR is not
assembled because the   transmembrane region is absent.
In  MT/ MT mice B lymphoid development is blocked
at the pro–B cell stage, although the V(D)J recombination
machinery is intact (Fig. 2 B; references 27 and 35). Ex-
pression of Blk(Y495F) on the  MT/ MT background
supported developmental progression beyond the block
imposed by the absence of functional Ig heavy chain, as ev-
idenced by decreased expression of CD43 and increased
expression of BP-1 and CD22 (Fig. 2 B and Table
S1, available at http://www.jem.org/cgi/content/full/
jem.20030729/DC1). Thus, the more mature B progenitor
population that emerged when  MT/ MT mice were
supplemented with the Blk(Y495F) transgene was similar
to the one that accumulated when the transgene was ex-
pressed on a wild-type or RAG-deficient background.
Moreover, as we observed on the RAG-deficient back-
ground, the late pre–B cell marker CD25 (36) was not ex-
pressed in the B220  CD43int population from Blk(Y495F)
transgenic  MT/ MT mice (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20030729/DC1), de-
spite the ability of B progenitors from these animals to ad-
vance to   light chain rearrangement (see below).
Initiation of    Rearrangement in Blk(Y495F) Transgenic
 MT/ MT Mice. Light chain rearrangement is sup-
pressed in homozygous  MT mice and productive rear-
rangement of a  MT allele fails to enforce allelic exclusion
(35). To determine whether active Blk could drive devel-
opmental progression to   rearrangement in the absence of
a pre-BCR, VHDJH, DJH, and V J  rearrangements were as-
sayed in the bone marrow of Blk(Y495F) transgenic  MT/
 MT mice and nontransgenic  MT/ MT littermates at 4
wk of age (Fig. 3 A). In Blk(Y495F) transgenic mice, a
striking increase in completed V J  rearrangement was ob-
served (Fig. 3 A, top).
Detection of completed rearrangements, however, is not
a direct indicator of recombinase activity at a given locus be-
cause differences in the frequency of rearrangement can be
masked by differential outgrowth and survival of cells after
completion of recombination. Indeed, when we examined
completed VHDJH and DJH rearrangements we observed no
significant difference between transgenic and wild-type
bone marrow (Fig. 3 A, second and third panels from top).
To evaluate recombinase activity at   and heavy chain loci
directly, we assayed signal end recombination intermediates,
Figure 3. Activation of   rearrangement and suppression of VH to DJH
rearrangement in  MT/ MT mice expressing the Blk(Y495F) transgene.
(A) Assay for completed rearrangements at Ig  and   loci. V J , DJH, or
VHDJH rearrangements were assayed by PCR in bone marrow cells from
Blk(Y495F) transgenic (lanes 4–6) or nontransgenic (lanes 1–3)  MT/
 MT mice. Samples were diluted serially fivefold before amplification.
Products were separated by gel electrophoresis and detected by hybridization
to radiolabeled, locus-specific probes. Amplification of a nonrearranging
locus (CD14, bottom) was performed as a control. (B) Assay for DNA
cleavage at V(D)J recombination signal sequences. Double strand DNA
breaks at the J 2 recombination signal sequence (top) or the 5  recombination
signal sequence of DFL16.1 (middle) were detected in bone marrow
DNA from nontransgenic (lanes 1–3) or transgenic (lanes 4–6)  MT/
 MT mice by ligation-mediated PCR. Samples were diluted serially five-
fold before amplification. Products were detected as in A.Pre–BCR Signaling by Active Blk 1868
an indicator of ongoing V(D)J rearrangement, by ligation-
mediated PCR. In the bone marrow of Blk(Y495F) trans-
genic  MT/ MT mice, double strand DNA breaks at the
J 2 recombination signal, which indicate ongoing V  to J 
rearrangement, were at least 25 times more abundant than in
nontransgenic  MT/ MT littermates (Fig. 3 B, middle). In
contrast, recombination signal ends associated with DFL16,
which indicate continuing VH to DJH rearrangement, were at
least five times less abundant in transgenic  MT/ MT ani-
mals than in nontransgenic  MT/ MT littermates (Fig. 3
B, top). Taken together, then, these observations provide
direct evidence that the Blk(Y495F) transgene mimics the
ability of the pre-BCR to activate V  to J  rearrangement
and suppress VH to DJH rearrangement.
Figure 4. Blk(Y495F) relieves selection for productive
heavy chain gene rearrangement. Nucleotide sequences
of VHDJH junctions from nontransgenic or Blk(Y495F)
transgenic littermates are shown. Genomic DNA was
purified from sorted B220  CD43  bone marrow cells
of 3-wk-old nontransgenic or Blk(Y495F) transgenic
mice. VHJ558-D-JH3 junctions were amplified by
PCR. Nucleotide sequences of individual, cloned
junctions are displayed. The 3  and 5  ends of germline
VHJ558 and JH3 segments, respectively, are shown at
the top. For each entry below, the 3  end of sequence
derived from VHJ558 and the 5  end of sequence derived
from JH3 are separated by sequence derived from the D
segment and any N or P nucleotide additions. Non-
productive rearrangements are shaded. The difference
in abundance of nonproductively rearranged alleles
from transgenic and nontransgenic mice was highly
significant (P   0.000001).Tretter et al. 1869
Relief of Selection for Functional Rearrangement at the Heavy
Chain Locus in Blk(Y495F) Transgenic Mice. B cell pro-
genitors that do not assemble a functional heavy chain gene
are eliminated by apoptosis. We wished to test whether the
Blk(Y495F) transgene relieves selection for functional
heavy chain gene rearrangement at this checkpoint. VHDJH
joints were amplified by PCR from sorted B220  CD43 
bone marrow cells of three 3–4-wk-old Blk(Y495F) trans-
genic mice and three nontransgenic littermates (Fig. 4). Of
42 VHJ558-D-JH3 rearrangements obtained from nontrans-
genic mice, 6 (14.3%) were found to be nonproductive,
whereas of 45 VHJ558-D-JH3 rearrangements isolated from
Blk(Y495F) transgenic mice, 30 (66.7%) were nonproduc-
tive. The increased representation of nonproductive rear-
rangements in transgenic mice is highly significant (P  
0.000001) and approximates the level expected for random
rearrangement in the absence of selection. Similar results
were obtained when rearrangements were amplified from
unsorted bone marrow cells (unpublished data). These re-
sults are consistent with the interpretation that constitu-
tively active Blk relieves the selection for functional heavy
chain rearrangement at the pro-B to pre-B transition by
enabling cellular survival in the absence of the pre-BCR.
Peripheral Accumulation of IgM  B Lymphoid Progenitors in
Blk(Y495F) Transgenic Mice. B cell progenitors can accu-
mulate in secondary lymphoid tissues under conditions of
stress or polyclonal activation (37, 38), as well as in RAG- or
heavy chain–deficient mice expressing activated Ras in the
B lymphoid compartment (39, 40). This also occurred when
Blk(Y495F) was expressed in the B lineage. Although over-
all splenic structure and cellularity were not significantly af-
fected by the transgene, a substantial decrease in the percent-
age of B220  cells expressing IgM was seen in spleens of
3–5-wk-old transgenic animals relative to nontransgenic
littermates (16.9   2.4 in transgenic animals, 51.6   1.7
in nontransgenic controls; Fig. 5 A and Table S2, available
at http://www.jem.org/cgi/content/full/jem.20030729/
DC1). Most remaining B lymphoid cells were B220lo,
CD43int, CD22int, and BP-1high, suggesting that they were
derived from the B progenitor population that accumulates
in bone marrow. Consistent with this interpretation, splenic
RNA from transgenic mice contained transcripts corre-
sponding to RAG-2, TdT, VpreB (Fig. 5 B), and  5 (not de-
picted), whose expression is characteristic of lymphoid pro-
genitors. The B progenitors found in the spleens of young
transgenic mice were polyclonal (unpublished data), in con-
trast to the clonal tumors that arise in these mice after 6–12
mo. These observations suggest that in Blk(Y495F) trans-
genic mice, B cell progenitors emigrate to peripheral lym-
phoid organs in the absence of BCR expression.
Consequences of Blk Activation. The ability of Blk-
(Y495F) to mimic multiple pre-BCR signals suggested a
point of action near proximal targets of pre-BCR signaling.
Accordingly, basal tyrosine phosphorylation of Ig  (Fig. 6
A) and Syk (Fig. 6 B) were substantially increased in pro–B
cells from transgenic mice relative to pro–B cells from non-
transgenic animals.
The availability of matched, pro–B cell populations al-
lowed us to examine the effects of Blk activation on gene
expression in B lymphoid progenitors. Bone marrow cells
from transgenic and nontransgenic animals were maintained
with IL-7 for 10 d to obtain B220  CD43  cells ( 98% pu-
rity), from which RNA was isolated. Preparations from three
Figure 5. Appearance of cells bearing a B progenitor phenotype in
spleens of Blk(Y495F) transgenic mice. (A) Flow cytometric analysis. Single
cell suspensions from spleens of transgenic (left) or nontransgenic (right)
littermates (3–5 wk old) were stained with antibodies to the indicated
markers. Plots of BP-1, CD22, or CD43 versus IgM (bottom three pairs)
are gated on B220  cells. Numbers indicate the percentage of cells in the
corresponding quadrant. (B) Peripheral expression of immature B cell
markers in Blk(Y495F) transgenic mice. RNA was prepared from spleens
of nontransgenic (lanes 1–3) or transgenic (lanes 4–6) littermates and tran-
scripts encoding RAG-2, terminal nucleotidyl transferase (TdT), VpreB,
or actin were detected by RT-PCR. Products were diluted as indicated
above, fractionated by gel electrophoresis, and detected by staining with
ethidium bromide.Pre–BCR Signaling by Active Blk 1870
mice of each group were pooled and probes from pooled
RNA samples were hybridized to arrays representing 12,488
markers. Five replicate hybridizations were performed.
Of the genes assayed, 51 were scored as differentially ex-
pressed and of these, the 35 genes of known or inferred
function (Fig. 6 C) were assigned to 9 categories (Table
S3, available at http://www.jem.org/cgi/content/full/
jem.20030729/DC1) as defined by the Gene Ontology
Consortium (www.geneontology.org). More than one third
(13/35) of these genes encode markers or regulators of B
lymphoid development. Those up-regulated in transgenic
pro–B cells include CD22, CD20, Siat1 (siat1; reference 41),
SHP-1 (hcp; reference 42), CCR7 (ccr7; reference 43), and
Ig , as well as Irf-4 (lsirf; pip), which stimulates germline Ig 
transcription (44), Mef2C (mef2c), which stimulates expres-
sion of J chain (45), and CstF1 (cstf1), part of an RNA pro-
cessing complex that generates Ig  secretory transcripts (46).
Consistent with the ability of Blk(Y495F) to suppress heavy
chain rearrangement, VH transcripts (IgH V) were dimin-
ished in transgenic B220  CD43  cells. Down-regulation of
transcripts for the prostaglandin E2 receptor (ptgerep4), a pos-
itive regulator of apoptosis in B lymphoid cells (47), and the
IL-3 receptor (il3r) are also in agreement with the matura-
tion-promoting effects of active Blk. The results obtained by
microarray were confirmed by RT-PCR for five markers
that were overexpressed (ccr7, CD22, irf4, gem, and ifi203)
and four markers that were underexpressed (clf1, semB, tnfc,
and il3r) in transgenic cells (Fig. 6 D).
Discussion
We have shown that a constitutively active form of Blk,
expressed in the B lineage at a level comparable to that of
the endogenous protein, effects a suite of responses nor-
mally stimulated by productive rearrangement and expres-
sion of the   heavy chain, including: (a) increased prolif-
eration of CD43int  B progenitor cells, (b) enhanced
responsiveness of these cells to IL-7, (c) maturation as re-
flected by changes in phenotype, (d) suppression of VH to
DJH rearrangement, and (e) initiation of   rearrangement.
Figure 6. Targets of proximal and distal signaling in B cell progenitors from Blk(Y495F) transgenic mice. (A) Constitutive tyrosine phosphorylation of
Ig  in transgenic B cell progenitors. Lysates were prepared from pro–B cells of nontransgenic (lanes 1, 4, and 7) or transgenic (lanes 2, 5, and 8) mice, and
Ig  was immunoprecipitated (lanes 4–8). Control immunoprecipitations were performed from a thymocyte lysate (lanes 3 and 6) or with nonimmune
IgG (lanes 1–3). Undiluted (lanes 1–6) and twofold diluted (lanes 7 and 8) immunoprecipitates were fractionated by electrophoresis alongside whole cell
lysates (lanes 9–11). Phosphotyrosine (top) and Ig-  (bottom) were detected by sequential immunoblotting. Arrows mark the position of Ig . (B) Con-
stitutive tyrosine phosphorylation of Syk in transgenic B cell progenitors. Lysates were prepared from nontransgenic (lanes 1 and 2) or transgenic (lanes 3
and 4) pro–B cells as in A. Syk was immunoprecipitated (lanes 2 and 4) and control immunoprecipitations were performed with nonimmune IgG (lanes
1 and 3). Phosphotyrosine (top) and Syk (bottom) were detected by sequential immunoblotting. (C) Differential gene expression in pro–B cells from
transgenic and nontransgenic mice. 35 genes of known function that were differentially expressed in nontransgenic (left) and transgenic (right) pro–B cells
are shown. Each column corresponds to one microarray. Red represents expression above and green represents expression below the median value. Black
represents expression at the median and gray represents no detectable expression. (D) Confirmation of differential expression. Total RNA from nontrans-
genic (lanes 1–4) or transgenic (lanes 5–8) pro–B cells was reverse transcribed, diluted serially fourfold, and used as a template for amplification of the
transcripts indicated at right. Products were fractionated by gel electrophoresis and detected with ethidium bromide.Tretter et al. 1871
IL-7 may limit expansion of B cell progenitors in the
bone marrow. Exogenous IL-7 provokes an overexpansion
of B cell precursors (48), whereas in IL-7–deficient mice
the transition from the pro-B to pre-B stage is partially im-
paired (49). Assembly of a pre-BCR is associated with in-
creased responsiveness to IL-7 (50), perhaps reflecting con-
vergence of pre-BCR and IL-7 signals at the level of MAP
kinase activation (5). A similar increase in IL-7 sensitivity
was seen in progenitor B cells from Blk(Y495F) transgenic
mice. Increased responsiveness of pre-BCR–expressing
cells to IL-7 would present a selective growth advantage
when the availability of IL-7 is reduced, as may occur in
some stromal microenvironments (4). The increase in IL-7
sensitivity conferred by Blk(Y495F) may contribute to the
overrepresentation of B cell progenitors and the apparent
lack of selection for   heavy chain expression observed in
Blk(Y495F) transgenic mice. As BP-1 is induced by IL-7
(51), increased sensitivity to this lymphokine may in part
explain the BP-1high phenotype of B220  CD43int trans-
genic B progenitors.
Expression of active Blk in the B lineage of  MT/ MT
or RAG-2 /  mice advances development past the blocks
induced by these deficiencies. This is evident from de-
creased expression of CD43 and c-kit, increased expression
of CD24, and appearance of BP-1, CD2, and CD22. This
action of Blk resembles the effects of transgenic   heavy
chain (33, 52) or cross-linking of Ig  (11), both of which
support differentiation of RAG-deficient pro–B cells to
pre–B cells, with concomitant down-regulation of c-kit
and CD43 and increased expression of CD24 and CD2.
In several ways, however, Blk(Y495F) and   heavy chain
transgenes differ in the extent to which they support B cell
development. In the RAG-deficient setting,   heavy chain
drives the emergence of B220  CD43  cells (33, 34, 52),
whereas active Blk supports accumulation of a B220 
CD43int population. Moreover, CD25, a marker characteris-
tic of pre–B II cells (36), is acquired by RAG-deficient B
progenitors upon the introduction of   heavy chain (33) or
cross-linking of Ig   (11), but not in the presence of
Blk(Y495F). Lastly, BP-1, which is induced upon cross-link-
ing of Ig  on RAG-deficient pro–B cells (11), is expressed
in the predominant B progenitor population in Blk(Y495F)
transgenic RAG-2 /  mice but not in the progenitors that
accumulate in   transgenic RAG /  animals (11).
Thus, the predominant B progenitor phenotype in
Blk(Y495F) transgenic RAG-deficient animals is phenotypi-
cally identical to the B progenitor population that is ex-
panded in recombination-competent, Blk(Y495F) transgenic
mice, but less mature than the most advanced progenitors
observed in   transgenic RAG-deficient mice. This distinc-
tion suggests that the pre-BCR delivers additional signals,
perhaps supplied by activation of other BCR-associated ki-
nases, which effect further developmental progression.
The pre-BCR stimulates   gene rearrangement and sup-
presses heavy chain rearrangement. A functional pre-BCR,
however, is not essential for activation of light chain rear-
rangement, which occurs at a low level in the absence of
membrane-bound   chain or  5 (35, 53). Nonetheless, in
bone marrow B cell precursors from  MT/ MT mice, Ig
light chain gene rearrangement is attenuated and the inci-
dence of specific DNA cleavage at the   locus is greatly re-
duced (27, 35). Cross-linking Ig  reverses this attenuation
and suppresses ongoing V(D)J rearrangement at the heavy
chain locus (12).
With respect to V(D)J recombination, the effects of
Blk(Y495F) in a  MT/ MT background are similar to
those of Ig  cross-linking. In bone marrow B lineage cells,
  rearrangement is stimulated, whereas the yield of VH to
DJH recombination intermediates is reduced. The effects of
the Blk(Y495F) transgene on heavy and light chain rear-
rangement are likely not related to increased IL-7 sensitiv-
ity, which would have been expected to promote VH to
DJH recombination and suppress   rearrangement (54). In
the T lineage, Lck can supply functions associated with the
pre-TCR, including suppression of V  to D J  rearrange-
ment and promotion of TCR-  rearrangement (55). An
active Ras transgene promotes TCR-  rearrangement but
fails to stimulate allelic exclusion at the TCR-  locus (56),
suggesting that the ability of Lck to enforce allelic exclu-
sion at the TCR-  locus is not exerted through Ras. The
ability of activated Ras to induce   rearrangement in JH-
deficient mice (39) raises the possibility that Ras mediates
the stimulatory effect of Blk on   rearrangement.
Expression of Blk(Y495F) was associated with constitutive
tyrosine phosphorylation of Ig  and Syk, suggesting that the
most proximal sequels of pre-BCR signaling are mimicked
by Blk activation. A comparison of gene expression in
Blk(Y495F) transgenic and nontransgenic B cell progenitors
was used to identify direct or indirect targets of pre-BCR
signaling. Fewer than 1% of expressed markers exhibited sig-
nificant differences in levels of expression. Of the 21 anno-
tated genes whose expression increased in transgenic cells,
markers associated with development beyond the pro-B
stage were disproportionately represented ( 41%), validating
the expression screen and providing further evidence that ac-
tive Blk promotes developmental progression.
A recent report demonstrates that mice triply deficient in
Blk, Lyn, and Fyn suffer an attenuation of the pro–B to
pre–B cell transition, accompanied by deficiencies in tyro-
sine phosphorylation of PKC  and activation of nuclear
factor (NF)- B (25). In these animals the leakiness of the
developmental block, as well as intact tyrosine phosphory-
lation of Ig /Ig  and Syk, may reflect the action of resid-
ual tyrosine kinases such as Hck, Fgr, and Lck. In this light,
our studies of Blk(Y495F) transgenic animals are consistent
with and complementary to those obtained with the triple
mutant mice.
Impaired activation of the p50-p65 NF- B heterodimer
by the pre-BCR (25) seems unlikely to account for the
developmental defect seen in animals lacking Blk, Lyn,
and Fyn because B cell development is unimpaired in mice
deficient in p50 or p65 (RelA; references 57 and 58). NF-
 B was similarly active in nontransgenic and Blk(Y495F)
transgenic pro–B cells (unpublished data), although it re-
mains possible that differences in NF- B activity were
masked by the conditions of ex vivo culture. Nonetheless,Pre–BCR Signaling by Active Blk 1872
differential NF- B activity is not essential for maintaining
the differences in proliferation and developmental matu-
rity that we observed between transgenic and nontrans-
genic cell populations.
Despite their partial redundancy in supporting the pro-B
to pre-B transition, the functions of Blk may differ in detail
from those of other Src-related kinases expressed in B lym-
phoid cells. For example, a constitutively active form of
Lyn, unlike the Blk(Y495F) mutant, affects neither the
proliferation of B progenitors nor their responsiveness to
IL-7 (18). Although such differences are consistent with
nonequivalent roles for Blk and other Src-related kinases in
early B lymphoid development, the ability of Blk, Lyn, or
Fyn to sustain B cell development in the absence of the
other two kinases suggests considerable functional overlap.
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